Recent Finacing
Recent Raise
Numares develops and commercializes the AXINON automated NMR‑based in‑vitro diagnostics platform that uses machine learning to analyze metabolomic profiles from blood or urine for multi‑marker disease assessment.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at numares HEALTH.
